JMP Securities reissued their buy rating on shares of Kadmon Holdings Inc (NASDAQ:KDMN) in a research report released on Monday morning.

Several other brokerages also recently issued reports on KDMN. Jefferies Group reissued a buy rating and set a $10.00 price target (down from $12.00) on shares of Kadmon Holdings in a report on Thursday, November 10th. HC Wainwright restated a buy rating on shares of Kadmon Holdings in a research report on Monday, August 22nd. Citigroup Inc. assumed coverage on shares of Kadmon Holdings in a research report on Monday, August 22nd. They issued a neutral rating and a $12.00 price objective for the company. Finally, WBB Securities assumed coverage on shares of Kadmon Holdings in a research report on Monday, August 1st. They set a sell rating and a $7.50 price target for the company. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus price target of $14.10.

Shares of Kadmon Holdings (NASDAQ:KDMN) remained flat at $5.85 during midday trading on Monday. 2,848 shares of the stock traded hands. The company’s 50 day moving average is $6.06 and its 200-day moving average is $7.73. Kadmon Holdings has a one year low of $4.44 and a one year high of $10.48. The company’s market capitalization is $263.71 million.

Kadmon Holdings (NASDAQ:KDMN) last announced its quarterly earnings results on Wednesday, November 9th. The company reported ($4.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by $3.83. The company had revenue of $5.70 million for the quarter, compared to analysts’ expectations of $3.90 million. The firm’s quarterly revenue was down 49.6% compared to the same quarter last year. Analysts forecast that Kadmon Holdings will post ($10.63) EPS for the current fiscal year.

In other news, major shareholder Daniel S. Loeb acquired 19,611 shares of the firm’s stock in a transaction that occurred on Wednesday, September 14th. The stock was purchased at an average price of $7.79 per share, for a total transaction of $152,769.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Daniel S. Loeb acquired 81,781 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The shares were purchased at an average price of $9.39 per share, with a total value of $767,923.59. The disclosure for this purchase can be found here.

Hedge funds and other institutional investors have recently modified their holdings of the stock. KCG Holdings Inc. purchased a new position in shares of Kadmon Holdings during the third quarter worth about $102,000. California State Teachers Retirement System purchased a new position in shares of Kadmon Holdings during the third quarter worth about $126,000. BlackRock Institutional Trust Company N.A. purchased a new position in shares of Kadmon Holdings during the third quarter worth about $129,000. Omega Advisors Inc. purchased a new position in shares of Kadmon Holdings during the third quarter worth about $679,000. Finally, Beach Point Capital Management LP purchased a new position in shares of Kadmon Holdings during the third quarter worth about $1,480,000.

Kadmon Holdings Company Profile

Kadmon Holdings, Inc, formerly Kadmon Holdings, LLC, is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of small molecules and biologics. The Company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases.

5 Day Chart for NASDAQ:KDMN

Receive News & Stock Ratings for Kadmon Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon Holdings Inc and related stocks with our FREE daily email newsletter.